MDS Nordion of Kanata, Ontario, reported last month that it will enlarge its operations in a $12.3 million expansion that will include a 48,000-sq-ft building with space for radiopharmaceutical production, laboratories, packaging, shipping, and
MDS Nordion of Kanata, Ontario, reported last month that it will enlarge its operations in a $12.3 million expansion that will include a 48,000-sq-ft building with space for radiopharmaceutical production, laboratories, packaging, shipping, and warehousing. The company also plans to expand its cobalt-60 production facility by 5000 sq ft. The project will be complete by August 1999, according to the Canadian radiopharmaceutical firm. In addition to cobalt-60, MDS Nordion processes and distributes molybdenum that it receives from Atomic Energy of Canada (AECL).
MRI Long Covid Study Reveals Link Between Lower Pulmonary Gas Exchange and Cognitive Dysfunction
November 26th 2024For patients with Long Covid, lower pulmonary gas exchange may be associated with lower gray and white matter volume, according to new MRI research to be presented at the Radiological Society of North America (RSNA) conference.
New DEXA Scan Study Links Thyroid Medication Levothyroxine to Higher Bone Loss Risk in Seniors
November 25th 2024Use of the medication levothyroxine, commonly prescribed for hypothyroidism, was associated with greater long-term loss of total body bone mass in seniors, according to new DEXA research to be presented at the Radiological Society of North America (RSNA) conference.